Hiraishi, Y., S. Nandakumar, S.O. Choi, J.W. Lee and Y.C. Kim et al., 2011. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine, 29: 2626-2636.
CrossRef  |  Direct Link  |  

Muthu, S.E., S. Nandakumar and U.A. Rao, 2005. The effect of methanolic extract of Tamarindus indica Linn. on the growth of clinical isolates of Burkholderia pseudomallei. Indian J. Med. Res., 122: 525-528.
PubMed  |  Direct Link  |  

Nandakumar, S. and U. Kumaraguru, 2010. Heterologous CD8 T cell immune response to HSV induced by toll like receptor ligands. Cell. Immunol., 261: 114-121.
CrossRef  |  PubMed  |  Direct Link  |  

Nandakumar, S., C.W.T. Miller and U. Kumaraguru, 2009. T regulatory cells: An overview and intervention techniques to modulate allergy outcome. Clin. Mol. Allergy., 7: 5-5.
CrossRef  |  Direct Link  |  

Nandakumar, S., S.N. Woolard, D. Yuan, B.T. Rouse and U. Kumaraguru, 2008. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J. Virol., 82: 10820-10831.
CrossRef  |  Direct Link  |  

Ni, L., C.J. Ma, Y. Zhang, S. Nandakumar and C.L. Zhang et al., 2011. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunol. Cell Biol., 89: 535-539.
PubMed  |  Direct Link  |  

Parthiban, R., S. Shanmugam, V. Velu, S. Nandakumar and E. Dhevahi et al., 2009. Transmission of hepatitis C virus infection from asymptomatic mother to child in Southern India. Int. J. Infect. Dis., 13: e394-e400.
CrossRef  |  PubMed  |  Direct Link  |  

Rodrigues, L., S. Nandakumar, C. Bonorino, B.T. Rouse and U. Kumaraguru, 2009. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8⁺ T cell response. Mol. Immunol., 46: 1494-1504.
CrossRef  |  PubMed  |  Direct Link  |  

Sable, S.B., M. Cheruvu, S. Nandakumar, S. Sharma and K. Bandyopadhyay et al., 2011. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS One, 6: e22718-e22718.
CrossRef  |  PubMed  |  Direct Link  |  

Saravanan, S., V. Velu, N. Kumarasamy, E.M. Shankar and S. Nandakumar et al., 2008. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, Southern India. Trans. R. Soc. Trop. Med. Hyg., 102: 793-796.
CrossRef  |  PubMed  |  Direct Link  |  

Saravanan, S., V. Velu, N. Kumarasamy, E.M. Shankar and S. Nandakumar et al., 2008. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int. J. Infect. Dis., 12: 513-518.
CrossRef  |  PubMed  |  Direct Link  |  

Saravanan, S., V. Velu, N. Kumarasamy, S. Nandakumar and K.G. Murugavel et al., 2007. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in South India. World J. Gastroenterol., 13: 5015-5020.
PubMed  |  Direct Link  |  

Saravanan, S., V. Velu, S. Nandakumar, V. Madhavan and U. Shanmugasundaram et al., 2009. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J. Microbiol. Immunol. Infect., 42: 122-128.
PubMed  |  Direct Link  |  

Shah, D., S. Nandakumar, G.B. Jaishankar, S. Chilakala, K. Wang and U. Kumaraguru, 2011. Pre-term exposure patterns in neonatal intensive care unit alters immunological outcome in neonates. J. Allergy Ther., 2: 106-106.
CrossRef  |  Direct Link  |  

Shanmugam, S., V. Velu, S. Nandakumar, V. Madhavan and U. Shanmugasundaram et al., 2008. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India. J. Microbiol. Biotechnol., 18: 1722-1728.
PubMed  |  Direct Link  |  

Sow, F.B., S. Nandakumar, V. Velu, K.L. Kellar and L.S. Schlesinger et al., 2011. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis, 91: 314-321.
CrossRef  |  PubMed  |  Direct Link  |  

Velu, V., S. Nandakumar, S. Shanmugam and S.P. Thyagarajan, 2007. Persistence of anti-HBs titers after two different doses of Genevac B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J. Gastroenterol., 26: 48-48.
PubMed  |  Direct Link  |  

Velu, V., S. Nandakumar, S. Shanmugam, E.M. Shankar, S. Thangavel, P.S. Kulkarni and S.P. Thyagarajan, 2007. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatric Infect. Dis. J., 26: 1038-1041.
PubMed  |  Direct Link  |  

Velu, V., S. Nandakumar, S. Shanmugam, S.S. Jadhav, P.S. Kulkarni and S.P. Thyagarajan, 2007. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J. Gastroenterol., 13: 3084-3089.
PubMed  |  Direct Link  |  

Velu, V., S. Saravanan, S. Nandakumar, E. Dhevahi and E.M. Shankar et al., 2008. Transmission of a determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers. Jpn. J. Infect. Dis., 61: 73-76.
PubMed  |  Direct Link  |  

Velu, V., S. Saravanan, S. Nandakumar, E.M. Shankar and A. Vengatesan et al., 2008. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. World J. Gastroenterol., 14: 3534-3540.
PubMed  |  Direct Link  |  

Vijayakumar, V., M. Shraddha, N. Subhadra, S. Saravanan, T. Sundararajan and S.P. Thyagarajan, 2004. Immunogenicity and safety of 10 mg and 20 mg doses of Genevac-B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J. Gastroenterol., 23: 34-35.
PubMed  |  Direct Link  |